Clinical Trials Logo

Filter by:
NCT ID: NCT01089556 Completed - Clinical trials for Diabetic Neuropathy, Painful

A Study in Painful Diabetic Neuropathy

COMBO-DN
Start date: March 2010
Phase: Phase 3
Study type: Interventional

This study will investigate the efficacy of a combination treatment of duloxetine + pregabalin compared with the maximal dose of each drug in monotherapy, in patients with diabetic peripheral neuropathic pain (DPNP) who have not responded to the standard recommended dose of either drug. It will provide an answer to a common clinical question, namely, is it better to increase the dose of the current monotherapy or to combine both treatments early on, in patients who do not respond to standard doses of duloxetine or pregabalin.

NCT ID: NCT01088841 Completed - Clinical trials for Appetite and General Nutritional Disorders

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Start date: April 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the functional significance of sweet taste receptors in the secretion of GI satiety peptides by using a specific sweet taste receptor antagonist to block sweet taste perception in the gut.

NCT ID: NCT01087918 Completed - Spinal Cord Injury Clinical Trials

Lokomat Versus Strength Training in Chronic Incomplete Spinal Cord Injury

Start date: July 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this pilot study is to investigate whether gait specific robotic supported bodyweight supported treadmill training and lower extremity strength training have similar beneficial effects on walking function and other outcomes.

NCT ID: NCT01086761 Terminated - Clinical trials for Wet Age-Related Macular Degeneration

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Start date: March 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of MP0112 (a novel, potentially long acting VEGF inhibitor) in patients with wet Age Related Macular Degeneration.

NCT ID: NCT01085669 Recruiting - Infection Clinical Trials

Infection Rate of Vertical Expandable Prosthetic Titanium Rib Implants (VEPTR)

Start date: September 2009
Phase: N/A
Study type: Observational

The study is conducted to analyse the infection rate in children treated with VEPTR-Implants for severe spine or thoracic deformities.

NCT ID: NCT01085370 Completed - Clinical trials for Acute Stress Disorder

Psychological Interventions in Children After Road Traffic Accidents or Burns

PICARTA-B
Start date: April 2010
Phase: N/A
Study type: Interventional

Within a randomized controlled design the effects of a brief early psychological intervention (child, parents) after road traffic accidents or burns shall be examined in a sample of 120 children and adolescents (aged 2 to 16 years). During the first seven days after the accident a screening for the risk of developing a posttraumatic stress disorder is conducted to divide the participants into a "high risk" and a "low risk" group. Participants with a low risk are excluded from the intervention study but reassessed six months after their accident to validate the screening instrument. After a baseline assessment within 14 days after the accident participants of the high risk group are randomly assigned to an intervention group (n = 60) or a control group (n = 60). The latter receive standard medical care. Children of the intervention group are provided with a brief age appropriate two-session intervention that includes a detailed reconstruction of the accident, psychoeducation and discussion of helpful coping strategies. Both the control and the intervention group are reassessed by blind raters at 3 and 6 months after the accident. Assessment of outcome includes measures of posttraumatic stress symptoms, depression, anxiety, behavior, and health-related quality of life.

NCT ID: NCT01084330 Completed - Clinical trials for Advanced Gastric Cancer

Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer

Start date: April 2010
Phase: Phase 2
Study type: Interventional

A clinical trial to determine the effectiveness and safety of AUY922 compared to other drugs known to be effective against gastric cancer in second line therapy for patients who have failed one line of chemotherapy.

NCT ID: NCT01083732 Completed - Clinical trials for Venous Thromboembolism

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Start date: March 2010
Phase: Phase 2
Study type: Interventional

To investigate the safety and tolerability of dabigatran etexilate solution in children and to obtain preliminary pharmacokinetic/pharmacodynamic data

NCT ID: NCT01083017 Completed - Hypertension Clinical Trials

Resistant Arterial Hypertension Cohort Study

RAHyCo
Start date: April 2011
Phase:
Study type: Observational

The purpose of this study is to investigate the epidemiology of resistant hypertension, evaluate the efficacy and feasibility of a standardized drug treatment regimen (including the randomization of two doses of the diuretic used - chlorthalidone), study two interventions in the group of patients that is non-compliant, and study environmental and genetic variables of individuals with resistant hypertension in a family design.

NCT ID: NCT01082874 Completed - Clinical trials for Cardiovascular Disease

PeriOperative ISchemic Evaluation-2 Trial

POISE-2
Start date: July 2010
Phase: Phase 3
Study type: Interventional

Major surgeries not involving the heart are common, and major heart problems during or after such surgeries represent a large population health problem. Few treatments to prevent heart problems around the time of surgery have been tested. There is encouraging data suggesting that small doses of Acetyl-Salicylic Acid (ASA) and Clonidine, which are two medications, given individually for a short period before and after major surgeries may prevent major heart problems. The POISE-2 Trial is a large international study to test if ASA and Clonidine can prevent heart attacks and deaths from heart problems around the time of surgery.